 I was recently invited on to the Capital Employed Podcast to have a chat with Jon Kingston. We talked a little about my style of investing and then I pitched the tiny AIM listed company MyCelx Technologies Corp (MYX.LON).
You can listen to the show on Spotify, Youtube, Apple Podcasts and Google Podcasts. Cheers, David Disclosure: Long MYX.L
2 Comments
 I initially bought ECC Capital Corp (ECRO) back in February of this year after a much smarter investor than myself told me about it (Thanks Bill, you totally nailed it!).
 I'm happy to announce that the Svenda's Manual of OTC stocks database is now available for an annual subscription price of $179.
 In a former life ImmunoCellular Therapeutics Ltd (IMUC) was a biotechnology company focusing on cancer immunotherapy, now its just a cash shell with some potential.
 Apologies for the lack of activity on the blog in recent weeks, I've been busy working with my friend @Jansvenda to produce an updated version of the Svenda's Manual of OTC stocks.
 FullNet Communications Inc (FULO) is a tiny company trading on the pink-sheets, the float is low and it's shares are thinly traded. In some ways it is cheap, in others maybe not. Much like every other company I write up it's got plenty of hair on it.
 Getech PLC (GTC:LON) is a tiny little firm floating on the AIM market of the LSE. It currently languishes just above it's all time low and market sentiment toward the company is unequivocally bearish. Sounds like my kind of company.
My friend, Jan Svenda, has recently released an updated version of his OTC manual at a discounted price. The manual now includes 2019 updates, financials for 36 'dark' companies and a lower price, down from $399 to $149.
I like to use this manual to generate ideas and to see Jan's opinion of OTC stocks I have found myself, it's also useful to look up stocks from the old Walker's manuals to see if the companies are still in business and how they are performing. Over to Jan with a bit more info.  Nuvectra Corp. (NVTRQ) commenced Chpt. 11 bankruptcy proceedings on November 12th 2019. The share price took a nose dive from $1.39 to $0.22, since then it's been trading in the $0.10-0.20 range.
Upon first glance it looks like game over for the common, but sometimes looks can be deceiving. |
David J. FloodUK based Investor. I focus Archives
February 2023
Categories
All
BLOGS I FOLLOW
No Name Stocks Svenda's Manual of OTC Stocks Caveat Emptor Stocks Leaven Partners OTC Adventures Nothing But Net Nets Clark Street Value Value Investing Blog Alpha Vulture Deep Value Investments OddballStocks Value Stock Geek Barel Karsan - Value Investing Shadow Stock Hidden Value Yet Another Value Blog Streets Of Value TES Optimal Value Investing The Bad Investor Undervalued Japan Liquidation Almanac Adventures in Capitalism White Chip Stocks Light Blue Value Global Investing Insight Mesaba Range Value The Market Plunger Neto's Notes Battleship Investing Blog The Investment Long-List Oceania Value Grahamian Value Digest Stock Speaking Canadian Value Stocks Analyzing Bargain Stocks MicroValue Hidden Gem Investing |
RSS Feed